Cipla, Hetero get DCGI’s nod to launch Remdesivir forCovid-19 treatment
India's Drug Regulator gave permission to Hetero and Cipla to manufacture and market antiviral drug…
3 years ago
India's Drug Regulator gave permission to Hetero and Cipla to manufacture and market antiviral drug…